In the clinical setting, we previously showed that the circulating levels of neutrophil degranulation products (MMP-8, MMP-9, MPO and NE) peak in stroke patients receiving r-tPA during the first hour after drug administration [7]. Here, MMP9 is linked to stroke disorder.